EXCEED THE SPACE PROVIDED. The hydroxysteroid sulfotransferase (SULT2A) enzymes detoxify drugs, xenobiotics, mono-hydroxy bile acids, and bioactivate hydroxy methyl polycyclic aromatic hydrocarbon carcinogens in toxicant target tissues such as the liver. Because sulfated steroids are generally receptor inactive, SULT2A enzymes also function as pivotal hormone- deactivating enzymes in the liver, and have the distinctive capacity to modulate the expression of hormone- responsive genes. The principal SULT2A isoform in rat liver is SULT2A-40/41. We have new evidence in support of a novel and complex dual control mechanism in the transcriptionalregulation of glucocorticoid-inducible SULT2A-40/41, and have identified the critical c/s-acting gene sequences in SULT2A-40/41 that control glucocorticoid-inducible expression by both physiological (glucocorticoid receptor-saturating concentrations)and pharmacological doses of glucocorticoid (concentrations of steroid that prevail during the stress response and would be expected to activate alternative nuclear receptors). In addition, we have established that in adult male mouse hepatocytes, the functional homolog of SULT2A-40/41 undergoes programmed gene silencing as a consequence of mechanisms that are insensitive to treatment with the potent histone deacetylaseinhibitor, trichostatin A, suggesting that epigenetic mechanisms regulate the expression of this gene during development. The hypothesis of the proposed research is three-fold. (1) The induction of rat hepatic SULT2A-40/41 gene expression by physiological concentrations of glucocorticoid occurs as a consequence of glucocorticoid- receptor-mediated induction of liver-enriched transcription factors (such as C/EBP and HNF-1), which then bind to consensus sequences in the proximal S'-flanking region of the SULT2A-40/41 gene and activate transcription. (2) Pharmacological doses of dexamethasone activate an orphan member of the nuclear receptor superfamily, which then binds to a c/s-acting inverted repeat element with zero intervening bases (IRO) in a more distal portion of the 5'-flanking region of the SULT2A-40/41 gene and activate gene transcription. (3) In male mouse hepatocytes, the silencing of basal and glucocorticoid-inducible SULT2A gene expression is produced by the programmed hypermethylation of critical CpG dinucleotides in the mouse STI|LT2A gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES005823-14
Application #
7035387
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Balshaw, David M
Project Start
2002-04-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2008-03-31
Support Year
14
Fiscal Year
2006
Total Cost
$290,997
Indirect Cost
Name
Wayne State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Barrett, Kathleen G; Fang, Hailin; Cukovic, Daniela et al. (2015) Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation. Drug Metab Dispos 43:1061-70
Rondini, Elizabeth A; Fang, Hailin; Runge-Morris, Melissa et al. (2014) Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells. Drug Metab Dispos 42:361-8
Duniec-Dmuchowski, Zofia; Rondini, Elizabeth A; Tibbs, Zachary E et al. (2014) Expression of the orphan cytosolic sulfotransferase SULT1C3 in human intestine: characterization of the transcript variant and implications for function. Drug Metab Dispos 42:352-60
Barrett, Kathleen G; Fang, Hailin; Gargano, Mary D et al. (2013) Regulation of murine hepatic hydroxysteroid sulfotransferase expression in hyposulfatemic mice and in a cell model of 3'-phosphoadenosine-5'-phosphosulfate deficiency. Drug Metab Dispos 41:1505-13
Runge-Morris, Melissa; Kocarek, Thomas A; Falany, Charles N (2013) Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab Rev 45:15-33
Salman, Emily D; He, Dongning; Runge-Morris, Melissa et al. (2011) Site-directed mutagenesis of human cytosolic sulfotransferase (SULT) 2B1b to phospho-mimetic Ser348Asp results in an isoform with increased catalytic activity. J Steroid Biochem Mol Biol 127:315-23
Fu, Jiaqi; Fang, Hailin; Paulsen, Michelle et al. (2011) Regulation of estrogen sulfotransferase expression by confluence of MCF10A breast epithelial cells: role of the aryl hydrocarbon receptor. J Pharmacol Exp Ther 339:597-606
Bai, Qianming; Xu, Leyuan; Kakiyama, Genta et al. (2011) Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 214:350-6
Fu, Jiaqi; Weise, Amy M; Falany, Josie L et al. (2010) Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Res Treat 120:35-45
Cook, Ian T; Duniec-Dmuchowski, Zofia; Kocarek, Thomas A et al. (2009) 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation. Drug Metab Dispos 37:2069-78

Showing the most recent 10 out of 11 publications